HU9801951D0 - New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents
New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing themInfo
- Publication number
- HU9801951D0 HU9801951D0 HU9801951A HUP9801951A HU9801951D0 HU 9801951 D0 HU9801951 D0 HU 9801951D0 HU 9801951 A HU9801951 A HU 9801951A HU P9801951 A HUP9801951 A HU P9801951A HU 9801951 D0 HU9801951 D0 HU 9801951D0
- Authority
- HU
- Hungary
- Prior art keywords
- hexahydro
- napht
- producing
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9710852A FR2767825A1 (fr) | 1997-09-01 | 1997-09-01 | Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (4)
Publication Number | Publication Date |
---|---|
HU9801951D0 true HU9801951D0 (en) | 1998-11-30 |
HUP9801951A2 HUP9801951A2 (hu) | 2000-02-28 |
HUP9801951A3 HUP9801951A3 (en) | 2000-04-28 |
HU226059B1 HU226059B1 (en) | 2008-04-28 |
Family
ID=9510643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801951A HU226059B1 (en) | 1997-09-01 | 1998-08-31 | Novel disubstituted trans-3,4,4a,5,6,10b-hexahydro-2h-naphto[1,2-b][1,4]oxazine derivatives, process for producing them and pharmaceutical compositions containing them |
Country Status (18)
Country | Link |
---|---|
US (1) | US6025356A (hu) |
EP (1) | EP0899267B1 (hu) |
JP (1) | JP4417451B2 (hu) |
CN (1) | CN1088064C (hu) |
AT (1) | ATE229513T1 (hu) |
AU (1) | AU740928C (hu) |
BR (1) | BR9803933A (hu) |
CA (1) | CA2246482C (hu) |
DE (1) | DE69810034T2 (hu) |
DK (1) | DK0899267T3 (hu) |
ES (1) | ES2189108T3 (hu) |
FR (1) | FR2767825A1 (hu) |
HU (1) | HU226059B1 (hu) |
NO (1) | NO311218B1 (hu) |
NZ (1) | NZ331637A (hu) |
PL (1) | PL194533B1 (hu) |
PT (1) | PT899267E (hu) |
ZA (1) | ZA987963B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
AU2003268292A1 (en) * | 2002-08-30 | 2004-03-19 | Biostratum, Inc. | Inhibitors of post-amadori advanced glycation end products |
MXPA05011225A (es) * | 2003-04-18 | 2005-12-14 | Pharmacia & Upjohn Co Llc | Politerapias. |
FR2906249B1 (fr) | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP2098511A1 (en) | 2008-03-07 | 2009-09-09 | Solvias AG | Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
WO2009156458A1 (en) * | 2008-06-27 | 2009-12-30 | H. Lundbeck A/S | Novel phenolic and catecholic amines and prodrugs thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
US4540691A (en) * | 1984-04-13 | 1985-09-10 | Nelson Research & Development Co. | Dopamine agonists and use thereof |
US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
JPH05508408A (ja) * | 1990-06-15 | 1993-11-25 | ホイツトビー・リサーチ・インコーポレーテツド | ドーパミン作動性薬剤として有用な置換ナフトキサジン類 |
-
1997
- 1997-09-01 FR FR9710852A patent/FR2767825A1/fr active Pending
-
1998
- 1998-08-31 NZ NZ331637A patent/NZ331637A/xx not_active IP Right Cessation
- 1998-08-31 NO NO19984007A patent/NO311218B1/no not_active IP Right Cessation
- 1998-08-31 US US09/144,025 patent/US6025356A/en not_active Expired - Lifetime
- 1998-08-31 CA CA002246482A patent/CA2246482C/fr not_active Expired - Fee Related
- 1998-08-31 PL PL328285A patent/PL194533B1/pl not_active IP Right Cessation
- 1998-08-31 HU HU9801951A patent/HU226059B1/hu not_active IP Right Cessation
- 1998-08-31 CN CN98119987A patent/CN1088064C/zh not_active Expired - Fee Related
- 1998-08-31 BR BR9803933-4A patent/BR9803933A/pt not_active Application Discontinuation
- 1998-09-01 DE DE69810034T patent/DE69810034T2/de not_active Expired - Lifetime
- 1998-09-01 DK DK98402155T patent/DK0899267T3/da active
- 1998-09-01 AT AT98402155T patent/ATE229513T1/de active
- 1998-09-01 PT PT98402155T patent/PT899267E/pt unknown
- 1998-09-01 AU AU83024/98A patent/AU740928C/en not_active Ceased
- 1998-09-01 ZA ZA987963A patent/ZA987963B/xx unknown
- 1998-09-01 JP JP24691098A patent/JP4417451B2/ja not_active Expired - Fee Related
- 1998-09-01 ES ES98402155T patent/ES2189108T3/es not_active Expired - Lifetime
- 1998-09-01 EP EP98402155A patent/EP0899267B1/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT899267E (pt) | 2003-04-30 |
DE69810034D1 (de) | 2003-01-23 |
DE69810034T2 (de) | 2003-08-14 |
NO311218B1 (no) | 2001-10-29 |
HUP9801951A2 (hu) | 2000-02-28 |
FR2767825A1 (fr) | 1999-02-26 |
AU740928C (en) | 2002-05-16 |
US6025356A (en) | 2000-02-15 |
ZA987963B (en) | 1999-03-04 |
BR9803933A (pt) | 2001-04-24 |
JP4417451B2 (ja) | 2010-02-17 |
PL328285A1 (en) | 1999-03-15 |
NO984007D0 (no) | 1998-08-31 |
CA2246482A1 (fr) | 1999-03-01 |
DK0899267T3 (da) | 2003-03-10 |
AU740928B2 (en) | 2001-11-15 |
JPH11130759A (ja) | 1999-05-18 |
ES2189108T3 (es) | 2003-07-01 |
ATE229513T1 (de) | 2002-12-15 |
NO984007L (no) | 1999-03-02 |
CN1088064C (zh) | 2002-07-24 |
EP0899267B1 (fr) | 2002-12-11 |
HUP9801951A3 (en) | 2000-04-28 |
HU226059B1 (en) | 2008-04-28 |
CA2246482C (fr) | 2002-11-26 |
HK1020340A1 (en) | 2000-04-14 |
EP0899267A1 (fr) | 1999-03-03 |
CN1222516A (zh) | 1999-07-14 |
NZ331637A (en) | 1999-07-29 |
AU8302498A (en) | 1999-03-11 |
PL194533B1 (pl) | 2007-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9700992D0 (en) | New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them | |
HU9801951D0 (en) | New disubstituted trans 3,4,4,4a,5,6,10b-hexahydro-2h-napht-[1,2-b]-1,4-oxazine derivatives, process for producing them and pharmaceutical compositions containing them | |
ZA964842B (en) | Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them | |
ZA200000336B (en) | Cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them. | |
AU7170496A (en) | New tetracyclic 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
HUT55783A (en) | Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives | |
PL311843A1 (en) | 1,2-bridge 1,4-dihydropyridine derivatives, method of obtaining them, their application and drugs containing such derivatives | |
AU2052395A (en) | New tetracyclic piperidine and 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
AU1494295A (en) | Novel aminoalkyl benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |